Statistical Issues in Drug Development Stephen S Senn
Publisher: Wiley-Interscience

This strategy is not as simple as it sounds, and issues, such as confidentiality and ownership, can be challenging. Lynn Torbeck, Statistical Solutions Lynn D. Simulation studies can play a vital role in improving the efficiency of the drug development process within the pharmaceutical industry, but only if they are well designed and conducted. April 2013, 22 (2) · Current Issue. Within the pharmaceutical industry, the improvement of drug discovery and development efficiency and the expected personalization of medicine have become vitally important issues. When handled properly, however, cross-company collaboration can result in a more efficient and profitable use of . Statistical issues in drug development, 2nd edition. Analysis of the drug development enterprise invariably reveals a “pipeline” problem—a disconnection between the substantial resources invested in developing new therapies and the rate at which innovative therapeutic products reach patients. Statistical Issues in Drug Development presents an essential and thought provoking guide to the statistical issues and controversies involved in drug development. The philosophical diseases of medicine and their cures: philosophy and ethics of medicine, vol. The author suggests co-opetition as a future model for collaboration in drug development. Against Counterfeit Drugs Continues. It is imperative therefore that a protocol or simulation plan is developed, documenting how the simulation Current Issue. Alert me to new issues of Statistical Methods in Medical Research.